Sage Mountain Advisors’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Sage Mountain Advisors’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,530	Closed	-$114K	–	387
2022 Q3	$114K	Sell	11,530 -99,580	-90%	-$985K	0.03%	241
2022 Q2	$1.08M	Hold	111,110	–	–	0.19%	76
2022 Q1	$1.09M	Sell	111,110 -6,660	-6%	-$65.8K	0.17%	98
2021 Q4	$1.17M	Buy	117,770 +1,860	+2%	+$18.4K	0.14%	118
2021 Q3	$1.15M	Buy	115,910 +74,570	+180%	+$740K	0.17%	104
2021 Q2	$413K	Buy	41,340 +20,000	+94%	+$200K	0.07%	260
2021 Q1	$215K	Buy	+21,340	New	+$213K	0.05%	288

Other funds holding EBACU

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Sage Mountain Advisors's EBACU Position: Q4 2022 in Review

Sage Mountain Advisors sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2022, closing a stake of 11,530 shares — an estimated $114K sold.

Sage Mountain Advisors first reported a position in EBACU in Q1 2021 and held it in 7 quarters. The position peaked at $1.17M in Q4 2021. 11 funds tracked by Wall St. Rank hold EBACU as of Q4 2022.

Sage Mountain Advisors reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
Sage Mountain Advisors sold 11,530 European Biotech Acquisition Corp. Units shares in Q4 2022, an estimated $114K.
Sage Mountain Advisors first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 7 quarters.
Sage Mountain Advisors's European Biotech Acquisition Corp. Units position peaked at $1.17M in Q4 2021.
11 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2022.

Based on Sage Mountain Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.